Commercial & Brand Strategy
- Brand positioning, value narrative, and messaging
- Portfolio and indication strategy (where to play / how to win)
- Channel strategy and stakeholder prioritization
- Field force effectiveness, targeting, and deployment
Brand Strategy • Market Access • Diligence • Launch
Commercial strategy and diligence support for life sciences growth decisions.
Biosimply helps biopharma, medtech, and HealthTech teams make better commercial decisions—faster. From brand and portfolio strategy to M&A planning, diligence, and launch execution, we bring a senior, commercial-first perspective grounded in real-world market dynamics.
Focus
Life Sciences Commercial
Work
Strategy → Execution
Style
Senior-led, pragmatic
Services
Modular support for life sciences teams—from rapid decision support to embedded leadership on high-stakes workstreams.
Commercial & Operational Due Diligence
- Commercial due diligence (CDD) for transactions and partnerships
- Market sizing, competitor landscapes, and scenario modeling
- Operational diligence on commercial readiness and execution risk
- M&A planning and integration decision support
Launch Planning & Market Access
- Launch strategy and cross-functional readiness planning
- Market access, payer strategy, and contracting support
- Coverage pathways and benefit design (medical vs pharmacy)
- Stakeholder engagement across payers, providers, and sites of care
Engagement formats
Project-based support, retainers, or fractional leadership for targeted workstreams.
How we work
A senior-led model designed for clarity, speed, and practical execution.
Senior-led delivery
Direct, hands-on support—no staffing pyramid. You get experienced judgment and fast iteration.
Structured thinking
Clear hypotheses, crisp workplans, and decision-ready outputs—built to align stakeholders quickly.
Execution-oriented
Recommendations built for real-world constraints across access, channels, and field execution.
Expertise
Senior-led advisory support across the life sciences commercial landscape—built for organizations operating at speed, under uncertainty.
Where we help most
- Brand and portfolio strategy for differentiated positioning
- Transaction support: M&A planning and diligence
- Launch planning from early strategy through execution readiness
- Market access strategies aligned to payer and site-of-care realities
- Field force model design, targeting, and effectiveness improvement
- Channel strategy across specialty distribution and sites of care
Therapeutic areas & modalities
Experience spans advanced therapeutic areas including oncology, CNS, and rare disease, and advanced modalities including cell & gene therapy, digital therapeutics, monoclonal antibodies (mAbs), ADCs, and surgical robotics.
Typical clients
Small, medium, and large enterprises across biopharmaceuticals, medical devices, HealthTech applications, and specialized sites of care.
About
Spencer Champagne is the President and Founder of Biosimply, LLC, providing senior-led commercial strategy support to life sciences organizations. Engagements often focus on high-stakes decisions—portfolio direction, brand strategy, transaction diligence, launch planning, and market access—where clarity, speed, and practical execution matter.
Biosimply works with small, medium, and large enterprises across biopharmaceuticals, medical devices, HealthTech applications, and specialized sites of care.
Contact
Send a note and I’ll respond quickly with suggested next steps.
Quick message
This uses your email app (no form backend required).
Email SpencerWant a real web form? I can wire this to HubSpot Forms, Zoho Forms, or a lightweight service like Formspree.